Could nasal vaccines provide better protection than mRNA vaccines? Here’s what preclinical trial’s have to say.
Could nasal vaccines provide better protection than mRNA vaccines? Here’s what preclinical trial’s have to say.
Brown University found that older adults have a smaller chance of having bad reactions after getting the Moderna vaccine compared to the Pfizerr vaccine
Moderna has recently made headlines by emphasising its focus on the development of a ‘super jab’ to tackle COVID-19, flu, and RSV.
Moderna has applied for an updated COVID-19 vaccine authorisation with the US Food and Drug Administration (FDA).
With winter looming, it’s worth taking stock of how prevalent COVID is right now and what can we expect over the next few months.
While we’re already seeing higher rates compared to this time last year, the scale and severity of 2023’s season are still unknown.
What does the future of flu vaccines look like?
Experts believe we are in the midst of the fourth wave of COVID-19. As of 8 November 2022, new cases have jumped by over 57% in Victoria to 2,213.